Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

4.950 -1.390 (-21.92%)
Streaming Delayed Price Updated: 9:53 AM EDT, May 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 579,027
Open 5.620
Bid (Size) 4.930 (200)
Ask (Size) 4.970 (200)
Prev. Close 6.340
Today's Range 4.840 - 5.720
52wk Range 5.540 - 22.25
Shares Outstanding 17,618,607
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
OptimizeRx Q1 Earnings Call Highlights ↗
OptimizeRx (NASDAQ:OPRX) reported first-quarter fiscal 2026 results that topped consensus expectations, while management lowered its full-year revenue outlook, citing continued caution among life... 
Via MarketBeat
Topics Earnings
OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance ↗
Via Chartmill

Performance

YTD
-60.1%
-60.1%
1 Month
-16.5%
-16.5%
3 Month
-50.8%
-50.8%
6 Month
-68.8%
-68.8%
1 Year
-46.2%
-46.2%

More News

Read More
News headline image
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corp (NASDAQ:OPRX) Beats Q4 Earnings Estimates but Offers Cautious 2026 Outlook ↗
Via Chartmill
News headline image
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Discover the top movers in Wednesday's pre-market session. ↗
Via Chartmill
News headline image
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
Whetstone Capital Exits GitLab as Enterprises Rethink AI-Driven Software Development Tools ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Whetstone Dumps 79,000 monday.com Shares Worth $15.3 Million ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
Why One Fund Still Has a $14 Million Bet on This Resale Stock Up 130% This Past Year ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BrightView Shares Down 30%: What a Full Fund Exit Signals for Investors ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Fund Added 415,000 Shares of a Software Stock Down 26% This Past Year ↗
Via The Motley Fool
News headline image
This Fund Just Bought $6 Million in Plug Power Stock — Is a Turnaround in Sight? ↗
Via The Motley Fool
Topics Economy Regulatory Compliance
News headline image
Whetstone Sells All Freshworks Shares ↗
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering Regulatory Compliance
News headline image
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
OptimizeRx Corp (NASDAQ:OPRX) Shows High-Growth Momentum with Strong Technical Breakout ↗
Via Chartmill
News headline image
OptimizeRx Corp (NASDAQ:OPRX) Delivers Strong Q3 Beat and Raises Guidance ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is OptimizeRx Corporation - Common Stock publicly traded?
Yes, OptimizeRx Corporation - Common Stock is publicly traded.
What exchange does OptimizeRx Corporation - Common Stock trade on?
OptimizeRx Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OptimizeRx Corporation - Common Stock?
The ticker symbol for OptimizeRx Corporation - Common Stock is OPRX on the Nasdaq Stock Market
What is the current price of OptimizeRx Corporation - Common Stock?
The current price of OptimizeRx Corporation - Common Stock is 4.950
When was OptimizeRx Corporation - Common Stock last traded?
The last trade of OptimizeRx Corporation - Common Stock was at 05/13/26 09:53 AM ET
What is the market capitalization of OptimizeRx Corporation - Common Stock?
The market capitalization of OptimizeRx Corporation - Common Stock is 87.21M
How many shares of OptimizeRx Corporation - Common Stock are outstanding?
OptimizeRx Corporation - Common Stock has 87M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.